Gerresheimer AG
XETRA:GXI
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
DE |
Gerresheimer AG
XETRA:GXI
|
3.3B EUR | 1.9 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
225B USD | 5.9 | ||
US |
Danaher Corp
NYSE:DHR
|
197.2B USD | 4.7 | ||
US |
Agilent Technologies Inc
NYSE:A
|
44.9B USD | 6.8 | ||
CH |
Lonza Group AG
SIX:LONN
|
37B CHF | 5.7 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.4B USD | 3.6 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.4T KRW | 14.8 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
32B USD | 9.1 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.3B USD | 3.6 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
24.9B USD | 8.4 | ||
US |
Waters Corp
NYSE:WAT
|
20.9B USD | 7.8 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.